Trade JnJ ^JNJ

Is Johnson & Johnson (JNJ) the Best Diversified Dividend Stock to Buy Now?

"Johnson & Johnson: Buy Rating Reaffirmed Despite Price Target Cut, Growth Prospects Highlighted"

Hamlin Capital Management LLC Acquires 94,147 Shares of Johnson & Johnson (NYSE:JNJ)

Barclays Cuts Johnson & Johnson (NYSE:JNJ) Price Target to $159.00

Johnson & Johnson (NYSE:JNJ) Shares Sold by Mitsubishi UFJ Asset Management UK Ltd.

Fort Washington Investment Advisors Inc. OH Boosts Stock Holdings in Johnson & Johnson (NYSE:JNJ)

LifePlan Financial LLC Purchases 2,978 Shares of Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) Stock Holdings Cut by Alpha Cubed Investments LLC

Atomi Financial Group Inc. Cuts Stock Position in Johnson & Johnson (NYSE:JNJ)

Clear Harbor Asset Management LLC Buys 2,549 Shares of Johnson & Johnson (NYSE:JNJ)

ARS Investment Partners LLC Decreases Position in Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) Stock Holdings Lowered by Brookmont Capital Management

Hamlin Capital Management LLC Increases Stock Position in Johnson & Johnson (NYSE:JNJ)

Lmcg Investments LLC Sells 63,413 Shares of Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) Trading Up 0.7% - Should You Buy?

Jim Cramer Likes Johnson & Johnson (JNJ) and the Kenvue Spin-Off - Here's Why

Johnson & Johnson's SWOT analysis: oncology portfolio drives growth amid challenges By Investing.com

Johnson & Johnson (NYSE:JNJ) Shares Up 1.6% After Strong Earnings

Johnson & Johnson (NYSE:JNJ) Price Target Cut to $169.00 by Analysts at Leerink Partners

Raymond James Has Lowered Expectations for Johnson & Johnson (NYSE:JNJ) Stock Price

Bank of America Cuts Johnson & Johnson (NYSE:JNJ) Price Target to $159.00

Johnson & Johnson (NYSE:JNJ) Q4 2024 Earnings Call Transcript

Culbertson A N & Co. Inc. Acquires 559 Shares of Johnson & Johnson (NYSE:JNJ)

Abacus Wealth Partners LLC Lowers Stake in Johnson & Johnson (NYSE:JNJ)

Central Bank & Trust Co. Sells 533 Shares of Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) Shares Bought by Hoese & Co LLP

Hoese & Co LLP Has $362,000 Stake in Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) Shares Acquired by ZWJ Investment Counsel Inc.

Zhang Financial LLC Has $1.79 Million Stock Holdings in Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) Shares Sold by Harbor Investment Advisory LLC

Overbrook Management Corp Reduces Stock Position in Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) Shares Sold by LaFleur & Godfrey LLC

Guinness Asset Management LTD Has $201.43 Million Stock Position in Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) Shares Sold by MassMutual Private Wealth & Trust FSB

Johnson & Johnson (JNJ) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst ... By GuruFocus

Johnson & Johnson (NYSE:JNJ) Shares Gap Down After Analyst Downgrade

1 Dividend Stalwart to Buy, 1 to Sell Post Earnings | Investing.com

Zacks Earnings Trends Highlights: Netflix and Johnson & Johnson - January 23, 2025 - Zacks.com

Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now - January 23, 2025 - Zacks.com

MediaPost Publications - Marketing Daily 01/23/2025

Plaintiff Argues Jury's $22M Punitive Damages Finding Undermines J&J's Talc Trial Win

FDA Approves Spravato Nasal Spray for Treatment-Resistant Depression

Johnson & Johnson clears a few hurdles, but Wall Street focuses on weak guidance | Morningstar

Johnson & Johnson (NYSE:JNJ) Shares Down 3.1% on Analyst Downgrade

Johnson & Johnson (NYSE:JNJ) Shares Gap Down Following Analyst Downgrade

Johnson & Johnson (JNJ) Stock Falls Over 3.8% Despite Beating Q4 Estimates

J&J reports Q4 sales, profit above estimates on cancer drug sales | Company Results - Business Standard

J&J CFO Joe Wolk: Anticipating 3% operational growth in 2025 despite 'significant' headwinds

Johnson & Johnson (NYSE:JNJ) Announces Earnings Results

J&J Tops Quarterly Profit Estimates on Cancer Drug Sales

Johnson & Johnson Projects 2025 Adj. Operational EPS Growth Of 8.7% At Midpoint, Excl. ITCI

Johnson & Johnson (JNJ) Q4 earnings

J&J's stock surrenders early gains as weak sales guidance offsets earnings beat | Morningstar

J&J's earnings beat estimates but guidance is mixed | Morningstar

J&J tops earnings estimates amid strong demand for cancer treatments By Investing.com

Johnson & Johnson Q4 Earnings: Revenue Hits $22.5 Billion, Adjusted EPS of $2. ...

Johnson & Johnson Q4 Profit Decreases, But Beats Estimates

Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2024 | The Manila Times

Johnson & Johnson (NYSE:JNJ) Holdings Raised by Pine Haven Investment Counsel Inc

Netflix, Nvidia lead Wednesday's market cap stock movers By Investing.com

Legend Biotech stock target cut to $91 by Jefferies By Investing.com

Johnson & Johnson (NYSE:JNJ) Shares Sold by Bridgewater Advisors Inc.

UMB Bank n.a. Has $46.19 Million Position in Johnson & Johnson (NYSE:JNJ)

M.E. Allison & CO. Inc. Takes $1.01 Million Position in Johnson & Johnson (NYSE:JNJ)

Diversify Wealth Management LLC Boosts Holdings in Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) Stock Holdings Raised by Ellsworth Advisors LLC

6,134 Shares in Johnson & Johnson (NYSE:JNJ) Purchased by Brady Martz Wealth Solutions LLC

J&J's Q4 Earnings Beat, Stock Down on Tepid 2025 Sales Guidance

Johnson & Johnson Earnings: Maintaining Fair Value Estimate Despite Heavy Stelara Hit in 2025 | Morningstar

Earnings call transcript: Johnson & Johnson Q3 2024 beats EPS forecast By Investing.com

Jim Cramer on Johnson & Johnson (JNJ): 'Make Good Money Just By Reinvesting Their Juicy Dividends'

FDA approves standalone use of J&J's ketamine-derived depression treatment | CNN

Earnings Picture Remains Strong: A Closer Look - January 22, 2025 - Zacks.com

J&J's Depression Drug Spravato Gets FDA Nod for Monotherapy Use - January 22, 2025 - Zacks.com

FDA Approves Johnson & Johnson's Spravato for Treatment-Resistant Depression

Johnson & Johnson (NYSE:JNJ) Shares Up 0.7% - What's Next?

Spravato (esketamine) Approved in the U.S. as the First and Only Monotherapy for Adults with Treatment-Resistant Depression

Stock Traders Buy Large Volume of Call Options on Johnson & Johnson (NYSE:JNJ)

Psoriasis Pipeline 2024: MOA, ROA, FDA-Approved Drugs, and Clinical Trial Progress Assessment by DelveInsight | Johnson and Johnson, Janssen Biotech, Leo Pharma, Merck, Novartis, Pfizer, AbbVie Inc

JNJ's SNDA For Spravato Monotherapy Gets FDA Approval For Treatment-Resistant Depression

FDA Approves Ketamine-based Nose Spray for Depression | Newsmax.com

RBC Capital cuts Intra-Cellular stock rating, hikes target to $132 By Investing.com

FDA approves Johnson & Johnson's nasal spray for depression as standalone treatment

depression: J&J's ketamine-based nasal spray Spravato approved by US FDA to treat depression - The Economic Times

FDA approves SPRAVATO as first monotherapy for MDD By Investing.com

Kinder Morgan, P&G, J&J, and more set to report earnings Wednesday By Investing.com

Ballast Inc. Has $3.26 Million Stock Position in Johnson & Johnson (NYSE:JNJ)

MNI US EARNINGS SCHEDULE - Industrials in Focus

Cadinha & Co. LLC Buys 1,825 Shares of Johnson & Johnson (NYSE:JNJ)

Bowman & Co S.C. Has $1.37 Million Stock Holdings in Johnson & Johnson (NYSE:JNJ)

Whitaker Myers Wealth Managers LTD. Makes New Investment in Johnson & Johnson (NYSE:JNJ)

Q4 Earnings: 3 Consumer Staples Titans on Deck

Sumitomo to market Johnson & Johnson's schizophrenia drug in Japan

Stock market today: Most Asian stocks fell after US equities declined

MicroStrategy joins Nasdaq-100 index: MSTR stock performance analysis 2024

Morning Note: Key Levels & Data Driving the Last Monday of 2024

Week ahead: Closing 2024 and First Economic data from 2025

Morning Note: Tesla Soars, AUDUSD Hits Key Support, Oil & SP500 Insights

Nikkei 225 up 1.39%: Japanese Stocks Rise Following Yen's Continued Weakness

Asian stock market today: most Asian stocks rise amid thin holiday trading

Stock market today: Nasdaq, S&P 500, Dow surge ahead of Christmas break